Plethico Pharmaceuticals (Delisted) share news and announcements
BSE: 532739
Last traded ₹9.05 on 13 Jun 2016
Delisted on 11 May 2018.
Plethico Pharmaceuticals share news and announcements
488 announcements, routine notices left out, newest first. Page 7 of 10.
Apr 2011
Mar 2011
31 Mar · Dividend
Board of Directors of the Company at its meeting held on March 31, 2011, inter alia, has recommended dividend @ 25% i.e. Rs. 2.50 ....31 Mar · Dividend
Baord of Directors of the Company at its meeting held on March 31, 2011 recommended dividend @ 25 % i.e. Rs. 2.50 per equity share of the Company.16 Mar · Board meeting
To consider the following : (1) approve and take on record the Quarterly / Yearly Audited Financial Results of the Company for the quarter / year ended on December 31, 2010; and (2) Recommendation of dividend for the year ending December 31, 2010, if any. (3) Any other matter with the permission of chair.16 Mar · Board meeting
Meeting of the Board of Directors of the Company will be held on March 31, 2011, inter alia, to consider the following: 1. Approve ....
Feb 2011
23 Feb · Results
Plethico Pharmaceuticals Limited had informed the Exchange that the Company will publish the Quarterly / Yearly Audited Financial Results for the last quarter / year ending on December 31, 2010, within a period of 60 days from the end of Financial Year i.e. March 01, 2011. The Company has now informed the Exchange that since the audit of all the overseas subsidiaries are in process and the Company expect that Audit of the Annual Accounts of overseas subsidiaries for the Financial year ended on December 31, 2010 would be completed by March 25, 2011 the company will be able to publish consolidated results forthwith upon such completion by March 31, 2011.23 Feb · Results
Publishing of Audited Financial Results for the Quarter/ year ended on December 31, 2010 in terms of clause 41 of the Listing Agreement, ....18 Feb · Management Presentation
15 Feb · Board meeting
Board of Directors of the Company has, at its meetings held on February 14, 2011 considered the following: (1) Allotment of 20,00,000 warrants at a price of Rs.400/- per warrant, convertible into equity shares of Rs.10/- each fully paid up at a premium of Rs.390/- per share on a preferential allotment basis, to M/s Arum Investments Private Limited. (2) Approval of Statement of Advertisement under section 58A of the Companies Act, 1956 for acceptance of Deposits.14 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 14, 2011, has considered the following: 1. Allotment of 20,00,000 ....14 Feb · Results
Company will publish the Quarterly / Yearly Audited Financial Results for the last quarter / year ending on December 31, 2010, within ....12 Feb · Board meeting
Inter alia, to consider the following items: (1) To allot 20,00,000 Warrants at a price of Rs. 400/- per warrant, convertible into equity shares of Rs.10/- each paid up at a premium of Rs. 390/- per share on a preferential allotment basis, to M/s Arum Investments Private Limited; (2) Approval of Statement of Advertisement under section 58A of the Companies Act, 1956 for acceptance of Deposits; (3) Any other matter as the Board may deem fit.12 Feb · Results
Company will publish the Quarterly / Yearly Audited Financial Results for the last quarter / year ending on December 31, 2010, within a period of 60 days from the end of Financial Year i.e. March 01, 2011.11 Feb · Board Meeting on Feb 14, 2011
Meeting of the Board of Directors of the Company will be held on February 14, 2011, inter alia, to consider the following items: ....
Jan 2011
10 Jan · Meeting
Members at the Extra Ordinary General Meeting (EGM) of the Company held on January 10, 2011, inter alia, have approved the following ....10 Jan · Meeting
An Extra-Ordinary General Meeting of the members of the Company held on January 10, 2011 and following decisions have been approved by the members of the Company: 1) Amendment in the Articles of Association of the Company for providing power to the Company and its Board of Directors in relation to the issuance of the warrants. 2) To offer, issue and allot 20,00,000 warrants at a price of Rs.400/- per warrant convertible into one equity share of Rs.10/- each fully paid up at price of Rs.400/- per share including premium of Rs.390 per share on preferential allotment basis.
Dec 2010
10 Dec · Meeting
With reference to the earlier announcement dated December 08, 2010 regarding to hold the Extra Ordinary General Meeting of the members of the Company on January 07, 2011, Plethico Pharmaceuticals ....9 Dec · Board meeting
Board of Directors of the Company has, at its meeting held on December 08, 2010 decided the following: (1) To consider, approve, issue and allot 20,00,000 warrants (each warrant being convertible into one equity share of Rs. 10/-) at a price of Rs. 400/- per warrant, on preferential basis to a person / entities other than Promoter in accordance with provision of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009 and its subsequent amendments made from time to time and other applicable rules, regulations and guidelines and subject to the approval of Shareholders, Statutory Authorities / Regulatory authorities or any other approval as may be required and authorize Mr. Shashikant Patel, Managing Director and / or to Mr. Amrish Kumar Chourasia, Company Secretary to do the needful for the said purpose. For the above purpose, the Extra-Ordinary General Meeting of the Company is proposed to be held on January 7, 2011.8 Dec · Board meeting
Board of Directors of the Company at its meeting held on December 08, 2010, inter alia, has decided the following: 1. To consider, ....6 Dec · Board meeting
Inter alia, to consider the following: 1) Issue of Share Warrants on preferential basis in compliance with the provisions of Chapter VII of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 as amended till date; and 2) Any other matter as the Board may deem fit.3 Dec · Board Meeting on Dec 08, 2010
Meeting of the Board of Directors of the Company will be held on December 08, 2010, inter alia, for issue of Share Warrants on preferential ....
Nov 2010
13 Nov · Updates
Plethico Pharmaceuticals Limited has received the approval for GMP clearance from the Therapeutic Goods Administration (TGA), Department of Health and Ageing, Australian Government for Company's manufacturing unit situated at Indore-Ahmedabad Road, NH 59 Village Dharavara, Post Kalaria, Indore (M.P.)12 Nov · Approval for GMP Clearance to Plethico Pharmaceuticals Ltd
Company has received the approval for GMP clearance from the Therapeutic Goods Administration (TGA), Department of Health and Ageing, ....2 Nov · Board meeting
To consider, approve and take on record the Quarterly Un-audited Financial Results of the Company for the quarter ended on September 30, 2010 and any other matter with the permission of Chair.
Oct 2010
Sep 2010